These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25214156)

  • 1. Urinary prostaglandin E2 metabolite and breast cancer risk.
    Cui Y; Shu XO; Gao YT; Cai Q; Ji BT; Li HL; Rothman N; Wu J; Yang G; Xiang YB; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2866-73. PubMed ID: 25214156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between urinary prostaglandin E2 metabolite and breast cancer risk: a prospective, case-cohort study of postmenopausal women.
    Kim S; Taylor JA; Milne GL; Sandler DP
    Cancer Prev Res (Phila); 2013 Jun; 6(6):511-8. PubMed ID: 23636050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Levels of Estrogens and PGE
    Kim S; Campbell J; Yoo W; Taylor JA; Sandler DP
    Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):383-388. PubMed ID: 27864342
    [No Abstract]   [Full Text] [Related]  

  • 4. Prospective study of urinary prostaglandin E2 metabolite and pancreatic cancer risk.
    Cui Y; Shu XO; Li HL; Yang G; Wen W; Gao YT; Cai Q; Rothman N; Yin HY; Lan Q; Xiang YB; Zheng W
    Int J Cancer; 2017 Dec; 141(12):2423-2429. PubMed ID: 28815606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of urinary prostaglandin E2 metabolite and colorectal cancer risk.
    Cai Q; Gao YT; Chow WH; Shu XO; Yang G; Ji BT; Wen W; Rothman N; Li HL; Morrow JD; Zheng W
    J Clin Oncol; 2006 Nov; 24(31):5010-6. PubMed ID: 17075120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary PGE-M Levels and Risk of Ovarian Cancer.
    Barnard ME; Beeghly-Fadiel A; Milne GL; Akam EY; Chan AT; Eliassen AH; Rosner BA; Shu XO; Terry KL; Xiang YB; Zheng W; Tworoger SS
    Cancer Epidemiol Biomarkers Prev; 2019 Nov; 28(11):1845-1852. PubMed ID: 31387969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary prostaglandin E2 metabolite and gastric cancer risk in the Shanghai women's health study.
    Dong LM; Shu XO; Gao YT; Milne G; Ji BT; Yang G; Li HL; Rothman N; Zheng W; Chow WH; Abnet CC
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3075-8. PubMed ID: 19861525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fruit and vegetable intake and urinary levels of prostaglandin E₂ metabolite in postmenopausal women.
    Kim S; Rimando J; Sandler DP
    Nutr Cancer; 2015; 67(4):580-6. PubMed ID: 25811232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Prospective Study of Urinary Prostaglandin E2 Metabolite, Helicobacter pylori Antibodies, and Gastric Cancer Risk.
    Wang T; Cai H; Zheng W; Michel A; Pawlita M; Milne G; Xiang YB; Gao YT; Li HL; Rothman N; Lan Q; Shu XO; Epplein M
    Clin Infect Dis; 2017 May; 64(10):1380-1386. PubMed ID: 28402440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers.
    Gross ND; Boyle JO; Morrow JD; Williams MK; Moskowitz CS; Subbaramaiah K; Dannenberg AJ; Duffield-Lillico AJ
    Clin Cancer Res; 2005 Aug; 11(16):6087-93. PubMed ID: 16115954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of urinary PGE-M, a biomarker of inflammation, occur in association with obesity, aging, and lung metastases in patients with breast cancer.
    Morris PG; Zhou XK; Milne GL; Goldstein D; Hawks LC; Dang CT; Modi S; Fornier MN; Hudis CA; Dannenberg AJ
    Cancer Prev Res (Phila); 2013 May; 6(5):428-36. PubMed ID: 23531446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary prostaglandin E2 metabolite and risk for colorectal adenoma.
    Shrubsole MJ; Cai Q; Wen W; Milne G; Smalley WE; Chen Z; Ness RM; Zheng W
    Cancer Prev Res (Phila); 2012 Feb; 5(2):336-42. PubMed ID: 22166248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of pro-inflammatory markers plasma C-reactive protein and urinary prostaglandin-E2 metabolite in colorectal adenoma risk.
    Davenport JR; Cai Q; Ness RM; Milne G; Zhao Z; Smalley WE; Zheng W; Shrubsole MJ
    Mol Carcinog; 2016 Aug; 55(8):1251-61. PubMed ID: 26333108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress, obesity, and breast cancer risk: results from the Shanghai Women's Health Study.
    Dai Q; Gao YT; Shu XO; Yang G; Milne G; Cai Q; Wen W; Rothman N; Cai H; Li H; Xiang Y; Chow WH; Zheng W
    J Clin Oncol; 2009 May; 27(15):2482-8. PubMed ID: 19380446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary prostaglandin E2 metabolite and pancreatic cancer risk: case-control study in urban Shanghai.
    Zhao J; Wang J; Du J; Xu H; Zhang W; Ni QX; Yu H; Risch HA; Gao YT; Gao Y
    PLoS One; 2015; 10(2):e0118004. PubMed ID: 25679523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary levels of melatonin and risk of postmenopausal breast cancer: women's health initiative observational cohort.
    Sturgeon SR; Doherty A; Reeves KW; Bigelow C; Stanczyk FZ; Ockene JK; Liu S; Manson JE; Neuhouser ML
    Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):629-37. PubMed ID: 24510738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer.
    Murphey LJ; Williams MK; Sanchez SC; Byrne LM; Csiki I; Oates JA; Johnson DH; Morrow JD
    Anal Biochem; 2004 Nov; 334(2):266-75. PubMed ID: 15494133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of urinary prostaglandin E2 metabolite and mortality among adults.
    Wen W; Yang G; Cai Q; Shu XO; Zheng W
    Sci Rep; 2022 Nov; 12(1):18905. PubMed ID: 36344823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary Melatonin in Relation to Postmenopausal Breast Cancer Risk According to Melatonin 1 Receptor Status.
    Devore EE; Warner ET; Eliassen AH; Brown SB; Beck AH; Hankinson SE; Schernhammer ES
    Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):413-419. PubMed ID: 28151704
    [No Abstract]   [Full Text] [Related]  

  • 20. Endogenous Estrogens, Estrogen Metabolites, and Breast Cancer Risk in Postmenopausal Chinese Women.
    Moore SC; Matthews CE; Ou Shu X; Yu K; Gail MH; Xu X; Ji BT; Chow WH; Cai Q; Li H; Yang G; Ruggieri D; Boyd-Morin J; Rothman N; Hoover RN; Gao YT; Zheng W; Ziegler RG
    J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27193440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.